Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Acutus Medical raises $nearly $21 million on its way to a hoped-for $31 million Series B round for its heart mapping device. Acutus Medical, fresh off a successful first-in-human trial of its heart-mapping technology, raised $21.6 million of a hoped-for $30.6 million Series B round, founder, president & CEO Randy Werneth told MassDevice.com today. San Diego-based Acutus developed a 3D cardiac electrical mapping system to identify areas of the heart muscle requiring ablation to treat atrial fibrillation. The system can deliver CT- or MRI-quality images of the heart’s electrical activity, the company claims. Last year Acutus raised $5.4 million to fund the initial trial, Werneth told us.
Help employers find you! Check out all the jobs and post your resume.
